Ottawa researchers have developed unique virus-derived particles that can kill human blood cancer cells in the laboratory and eradicate the disease in mice with few side effects.
While Dr. Bell and his colleagues have been investigating replicating viruses for the treatment of solid cancers for many years, with very promising results, this is the first major success they have had treating blood cancer (leukemia). It is also the first success they have had using a non-replicating virus-derived particle as opposed to a replicating virus.
“Our research indicated that a replicating virus might not be the safest or most effective approach for treating leukemia, so we decided to investigate whether we could make virus-derived particles that no longer replicate but still kill cancer,” said Dr. Conrad, a hematologist conducting research in the Blood and Marrow Transplant Program at The Ottawa Hospital, and currently completing his PhD at OHRI and uOttawa in the Department of Cellular and Molecular Medicine. “We were delighted to see that this novel therapy was very safe at high doses, and worked extremely well in our laboratory leukemia models. We hope to test this in patients in the near future.”
The researchers used a specific method and dose of UV light to transform regular replicating viruses into unique particles that could no longer replicate and spread, but could still enter cancer cells efficiently, kill them and stimulate a strong immune response against the cancer. These particles were able to kill multiple forms of leukemia in the laboratory, including samples taken from local patients who had failed all other therapies. Normal blood cells were not affected. This novel treatment was also successful in mouse models of leukemia. In fact, 80 per cent of the mice that received the therapy had markedly prolonged survival and 60 per cent were eventually cured, while all of the untreated mice died of their leukemia within 20 days.
“Leukemia is a devastating disease that can be very difficult to treat, and new therapies are urgently needed,” said Dr. Conrad. “While we’re still at the early stages of this research, I think this therapy holds a lot of promise because it appears to have a potent, long-lasting effect on leukemia without the debilitating side effects of many cancer therapies used in the clinic right now.
The Latest Bing News on:
- Why Polio, Once Nearly Eradicated, Is Reboundingon August 2, 2022 at 1:27 am
Poliomyelitis (“polio” for short) has been a cause of life-threatening paralysis for thousands of years. At the height of the biggest-ever outbreak in 1952, almost 60,000 cases with more than 3,000 ...
- Monkeypox vaccines: What to know about Imvamune, Imvanex, Jynneos, ACAM2000on August 1, 2022 at 8:44 am
Vaccines approved for monkeypox are available, but in limited supply. Currently, there are at least 3 vaccines approved for use against monkeypox in the EU and US. Imv ...
- More pandemics on the way with as many as 15,000 viruses out there: Reporton July 31, 2022 at 9:00 am
Infected animals secrete numerous virus particles before clinical signs appear ... health officials said that a type of poliovirus derived from vaccines had been detected in London sewage samples.
- Superbugs and viruses emerge with more pandemics on the way with as many as 15,000 in the worldon July 31, 2022 at 6:19 am
Hot on the heels of the coronavirus pandemic, the recent explosion of monkeypox cases in countries where the infection had not previously spread has raised the issue of what other viruses are out ...
- “Reactive strategy”: How polio crept back into the U.S.on July 27, 2022 at 9:30 am
Health agencies generally don’t test wastewater for signs of polio, which may have given virus time to circulate ...
- 'This isn’t normal': What to know about New York polio case, a rarity in the USon July 23, 2022 at 11:41 am
The New York patient appears to have a vaccine-derived strain of the virus, possibly transmitted ... commonly spread through contact with tiny particles of an infected person's feces in food ...
- 'This isn’t normal': What to know about New York polio case, a rarity in the USon July 21, 2022 at 4:14 pm
The polio vaccine is the best protection against potential outbreaks, health officials say. Here's what to know about polio.
- Virus Filtration Market Report 2022, Size, Share, Trends and Forecast to 2027on July 20, 2022 at 10:41 pm
Virus filtration refers ... biological therapeutics and plasma-derived product drug substances. It consists of a polymeric membrane barrier to retain virus particles on the surface and within ...
The Latest Google Headlines on:
The Latest Bing News on:
Non-replicating virus-derived particle
- U.S. polio case tied to viruses detected in U.K., Israel, suggesting silent spreadon July 29, 2022 at 5:55 pm
Genetic analysis of the virus responsible for the first case of polio in the United States in nearly a decade shows it is linked to vaccine-derived viruses recently detected in Jerusalem and London.
- Using the Blogon July 28, 2022 at 5:00 pm
(Beyond Pesticides, July 29, 2022) Perhaps attempting to capitalize on the recent U.S. Supreme Court decision limiting the U.S. Environmental Protection Agency’s (EPA’s) ability to regulate carbon ...
- Parvovirus B19on July 20, 2022 at 5:00 pm
The parvoviruses are dependent on help from host cells or other viruses to replicate. The autonomous ... is being incorporated on a parvovirus B19 particle. Parvovirus B19 is an excellent example ...
- Gel Electrophoresis News and Researchon July 17, 2022 at 4:59 pm
Researchers evaluated the pathogenicity and replication potential of SARS-CoV-2 VOC Omicron lineage, BA.2 in immunocompetent mice and hamsters. A recent study shows how a novel and integrated lab ...
- BA.2.75: A Dark Horse In The Covid Pandemicon July 10, 2022 at 5:00 pm
5 the replication advantage it possesses. FIGURE 4: Non-Spike protein ... mutated regions of the virus as they are typical targets for neutralizing antibodies derived from infection, vaccines ...
- Self-replicating probes are imminent – implications for SETIon July 8, 2022 at 7:29 am
Sagan favoured the existence of ETI on the basis of the Copernican principle and Tipler favoured the non-existence of ETI on the basis ... crucial to the Tipler argument was the role played by ...
- Novel inhalable COVID-19 vaccineon July 5, 2022 at 6:04 pm
The scientists developed an inhalable vaccine by combining SARS-CoV-2 RBD with lung spheroid cell-derived Exos (LSC-Exo) surface, i.e., RBD-Exo, to create a virus-like particle (VLP) that mimics ...
- Systemic Rotavirus Infectionon June 29, 2022 at 5:00 pm
Data derived from humans and animal model systems ... PCR (ssQRT-PCR), was applied to study the extraintestinal replication of virus strains EC (mouse) or RRV (monkey) following the oral ...
- HIV - 1 Nef: At the Crossroadson June 27, 2022 at 5:01 pm
Therefore, this effect represents increased infection efficiency for HIV-1 virions, and is distinct from Nef-dependent enhanced particle ... suppressed by the non-pathologic virus?
- Reprogrammed viruses as cancer therapeutics: targeted, armed and shieldedon September 10, 2020 at 6:28 pm
The four basic layers of specificity are: particle activation through ... were better environments for the replication of naturally oncolytic viruses, whereas non-transformed cells could control ...